COG vs. RENX, INHC, FDBK, IQAI, TRLS, DVRG, SENS, EMIS, CRW, and INS
Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Renalytix (RENX), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), and Instem (INS). These companies are all part of the "health information services" industry.
Cambridge Cognition vs. Its Competitors
Renalytix (LON:RENX) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.
Cambridge Cognition has a net margin of -10.07% compared to Renalytix's net margin of -1,191.75%. Renalytix's return on equity of 293.20% beat Cambridge Cognition's return on equity.
Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.
28.4% of Renalytix shares are owned by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are owned by institutional investors. 35.7% of Renalytix shares are owned by company insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Renalytix has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.
In the previous week, Renalytix's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.
Summary
Cambridge Cognition beats Renalytix on 6 of the 11 factors compared between the two stocks.
Get Cambridge Cognition News Delivered to You Automatically
Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cambridge Cognition Competitors List
Related Companies and Tools
This page (LON:COG) was last updated on 8/2/2025 by MarketBeat.com Staff
